/term/short-term-debt/BOM:533573 Alembic Pharmaceuticals (BOM:533573) Short-Term Debt
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alembic Pharmaceuticals Ltd (BOM:533573) » Definitions » Short-Term Debt

Alembic Pharmaceuticals (BOM:533573) Short-Term Debt : ₹4,305 Mil (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Alembic Pharmaceuticals Short-Term Debt?

Alembic Pharmaceuticals's Short-Term Debt for the quarter that ended in Mar. 2024 was ₹4,305 Mil.

Alembic Pharmaceuticals's quarterly Short-Term Debt declined from Sep. 2023 (₹7,844 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹4,305 Mil).

Alembic Pharmaceuticals's annual Short-Term Debt increased from Mar. 2022 (₹6,300 Mil) to Mar. 2023 (₹6,359 Mil) but then declined from Mar. 2023 (₹6,359 Mil) to Mar. 2024 (₹4,305 Mil).


Alembic Pharmaceuticals Short-Term Debt Historical Data

The historical data trend for Alembic Pharmaceuticals's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alembic Pharmaceuticals Short-Term Debt Chart

Alembic Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,605.00 2,999.00 6,299.90 6,358.60 4,304.50

Alembic Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,358.60 - 7,843.80 - 4,304.50

Alembic Pharmaceuticals Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Alembic Pharmaceuticals Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Alembic Pharmaceuticals's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Alembic Pharmaceuticals (BOM:533573) Business Description

Traded in Other Exchanges
Address
Alembic Road, Vadodara, GJ, IND, 390 003
Alembic Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company focuses on manufacturing and marketing generic pharmaceutical products across the globe. Alembic also operates a branded formulation business that covers a range of therapeutic areas such as dermatology, oncology, ophthalmology, and injectable formulations. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Alembic Pharmaceuticals (BOM:533573) Headlines

No Headlines